Preston G A, Lang J E, Maronpot R R, Barrett J C
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709.
Cancer Res. 1994 Aug 1;54(15):4214-23.
A cell culture model system has been used to study the susceptibility of cells to apoptotic cell death during different stages of neoplastic progression. This system consists of normal diploid Syrian hamster embryo (SHE) cells, two preneoplastic cell lines [tumor suppressor stage I (sup +I) and non-tumor suppressor stage II (sup -II)], and hamster tumor cell lines. Stage I preneoplastic cells are nontumorigenic immortal clones that suppress tumorigenicity when hybridized to tumor cells, whereas stage II cells have lost the ability to suppress tumorigenicity in cell hybrids. We refer to these two types of preneoplastic cells as sup +I and sup -II, respectively. Neoplastic progression is generally associated with cellular alterations in growth factor responsiveness. Therefore, to study the regulation of apoptosis in the system described above, cells were cultured in low serum (0.2%) as a means of withdrawing growth factors. In low serum, normal SHE cells were quiescent (labeling index of 0.2%), with little cell death. The sup +I cells showed a relatively low labeling index (1.6%) but, in contrast to the normal cells, died at a high rate (55% cell loss after 48 h) by apoptosis, as evidenced by morphology, DNA fragmentation, and in situ end-labeling of fragmented DNA. The apoptotic cells did not go through a replicative cycle while in low serum, implying that apoptosis was initiated in the G0/G1 phase of the cell cycle. The sup -II cell line showed a high labeling index (40%) after 48 h, but cell growth was balanced by cell death that occurred at approximately the same rate. The cells died, however, predominantly by necrosis. The tumor cell lines continued to proliferate in low serum, with high labeling indices (ranging from 27% to 43%) and a low level of apoptotic or necrotic cell death. To determine the relative ability of these cells to survive in vivo, normal SHE cells, sup +I cells, and sup -II cells were injected s.c. into nude mice. At 5 or 21 days after injection, the normal SHE cells were readily retrieved from the mice and grew well in culture. In contrast, few sup +I cells were retrieved 5 days after injection and no viable cells were retrieved after 21 days. Sup -II cells were not retrieved at either the 5-day or 21-day harvest, and histological examinations of the sites of injection showed the presence of macrophages, eosinophils, and neutrophils, indicating an inflammatory response associated with necrotic cell death.(ABSTRACT TRUNCATED AT 400 WORDS)
一种细胞培养模型系统已被用于研究细胞在肿瘤进展不同阶段对凋亡性细胞死亡的敏感性。该系统由正常二倍体叙利亚仓鼠胚胎(SHE)细胞、两种癌前细胞系[肿瘤抑制I期(sup +I)和非肿瘤抑制II期(sup -II)]以及仓鼠肿瘤细胞系组成。I期癌前细胞是无致瘤性的永生克隆,与肿瘤细胞杂交时可抑制致瘤性,而II期细胞在细胞杂交中已失去抑制致瘤性的能力。我们分别将这两种癌前细胞类型称为sup +I和sup -II。肿瘤进展通常与生长因子反应性的细胞改变有关。因此,为了研究上述系统中凋亡的调控,细胞在低血清(0.2%)中培养,作为去除生长因子的一种方法。在低血清中,正常SHE细胞静止(标记指数为0.2%),细胞死亡很少。sup +I细胞显示出相对较低的标记指数(1.6%),但与正常细胞相反,通过凋亡以高比率死亡(48小时后细胞损失55%),形态学、DNA片段化以及片段化DNA的原位末端标记证明了这一点。凋亡细胞在低血清中未经历复制周期,这意味着凋亡在细胞周期的G0/G1期启动。sup -II细胞系在48小时后显示出高标记指数(40%),但细胞生长与以大致相同比率发生的细胞死亡相平衡。然而,细胞主要因坏死而死亡。肿瘤细胞系在低血清中继续增殖,标记指数高(范围从27%到43%),凋亡或坏死性细胞死亡水平低。为了确定这些细胞在体内的相对存活能力,将正常SHE细胞、sup +I细胞和sup -II细胞皮下注射到裸鼠体内。注射后5天或21天,正常SHE细胞很容易从小鼠体内取出并在培养中生长良好。相比之下,注射后5天很少能取出sup +I细胞,21天后未取出存活细胞。在5天或21天收获时均未取出sup -II细胞,注射部位的组织学检查显示存在巨噬细胞、嗜酸性粒细胞和中性粒细胞,表明与坏死性细胞死亡相关的炎症反应。(摘要截断于400字)